BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16001142)

  • 1. Tenecteplase in the treatment of thrombosed hemodialysis grafts.
    Falk A; Harbour K
    Cardiovasc Intervent Radiol; 2005; 28(4):472-5. PubMed ID: 16001142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reteplase in the treatment of thrombosed hemodialysis grafts.
    Falk A; Guller J; Nowakowski FS; Mitty H; Teodorescu V; Uribarri J; Vassalotti J
    J Vasc Interv Radiol; 2001 Nov; 12(11):1257-62. PubMed ID: 11698623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis of clotted hemodialysis grafts with tissue-type plasminogen activator.
    Falk A; Mitty H; Guller J; Teodorescu V; Uribarri J; Vassalotti J
    J Vasc Interv Radiol; 2001 Mar; 12(3):305-11. PubMed ID: 11287506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the peripheral cutting balloon to treat hemodialysis-related stenoses.
    Vesely TM; Siegel JB
    J Vasc Interv Radiol; 2005 Dec; 16(12):1593-603. PubMed ID: 16371523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic angioplasty reduces thrombosis in virgin ePTFE arteriovenous dialysis grafts with greater than 50% stenosis: subset analysis of a prospectively randomized study.
    Martin LG; MacDonald MJ; Kikeri D; Cotsonis GA; Harker LA; Lumsden AB
    J Vasc Interv Radiol; 1999 Apr; 10(4):389-96. PubMed ID: 10229464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-Bonded Polytetrafluorethylene Does Not Improve Hemodialysis Arteriovenous Graft Function.
    Zea N; Menard G; Le L; Luo Q; Bazan HA; Sternbergh WC; Smith TA
    Ann Vasc Surg; 2016 Jan; 30():28-33. PubMed ID: 26256705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of alteplase and urokinase for pharmacomechanical thrombolysis of clotted hemodialysis access.
    Tan RY; Pang SC; Teh SP; Lee KG; Chong TT; Gogna A; Tan CS
    J Vasc Access; 2019 Sep; 20(5):501-506. PubMed ID: 30585114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteplase for hemodialysis access graft thrombolysis.
    Sofocleous CT; Hinrichs CR; Weiss SH; Contractor D; Barone A; Bahramipour P; Brountzos E; Kelekis D
    J Vasc Interv Radiol; 2002 Aug; 13(8):775-84. PubMed ID: 12171980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equivalent outcomes with standard and heparin-bonded expanded polytetrafluoroethylene grafts used as conduits for hemodialysis access.
    Davies MG; Anaya-Ayala JE; El-Sayed HF
    J Vasc Surg; 2016 Sep; 64(3):715-8. PubMed ID: 27183857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of Long Versus Short Thrombolysis Times for Acutely Thrombosed Hemodialysis Native Fistulas.
    Regus S; Lang W; Heinz M; Uder M; Schmid A
    Vasc Endovascular Surg; 2017 Jul; 51(5):233-239. PubMed ID: 28639916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
    Ponce D; Mendes M; Silva T; Oliveira R
    Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
    Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
    J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis with alteplase: a non-invasive treatment for occluded arteriovenous fistulas and grafts.
    Tseke P; Kalyveza E; Politis E; Giapraka N; Andriopoulos C; Balitsari A; Papatzikos L; Stavgianoudakis G
    Artif Organs; 2011 Jan; 35(1):58-62. PubMed ID: 20626738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patency rates and complications of Exxcel yarn-wrapped polytetrafluoroethylene grafts versus Gore-tex stretch polytetrafluoroethylene grafts: a prospective study.
    Ko PJ; Hsieh HC; Chu JJ; Lin PJ; Liu YH
    Surg Today; 2004; 34(5):409-12. PubMed ID: 15108078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Original report. Pulse-spray thrombolysis of thrombosed hemodialysis grafts with tissue plasminogen activator.
    Cooper SG
    AJR Am J Roentgenol; 2003 Apr; 180(4):1063-6. PubMed ID: 12646455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosed hemodialysis grafts: lyse and wait with tissue plasminogen activator or urokinase compared to mechanical thrombolysis with the Arrow-Trerotola Percutaneous Thrombolytic Device.
    Vogel PM; Bansal V; Marshall MW
    J Vasc Interv Radiol; 2001 Oct; 12(10):1157-65. PubMed ID: 11585881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent thrombosis of polytetrafluoroethylene dialysis fistulas after recent surgical thrombectomy: salvage by means of thrombolysis and angioplasty.
    Berger MF; Aruny JE; Skibo LK
    J Vasc Interv Radiol; 1994; 5(5):725-30. PubMed ID: 8000121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective multicenter study with a 1-year analysis of a new vascular graft used for early cannulation in patients undergoing hemodialysis.
    Glickman MH; Burgess J; Cull D; Roy-Chaudhury P; Schanzer H
    J Vasc Surg; 2015 Aug; 62(2):434-41. PubMed ID: 25953016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery.
    Flu H; Breslau PJ; Krol-van Straaten JM; Hamming JF; Lardenoye JW
    J Vasc Surg; 2008 Sep; 48(3):659-68. PubMed ID: 18572358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis versus surgical thrombectomy for the treatment of dialysis graft thrombosis: pilot study comparing costs.
    Vesely TM; Idso MC; Audrain J; Windus DW; Lowell JA
    J Vasc Interv Radiol; 1996; 7(4):507-12. PubMed ID: 8855526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.